Ceesay Abraham's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Sep 19, 2025
- Accession no.
- 0001193125-25-209062
- Filed
- Sep 19, 2025
- Trade date
- Sep 17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.01M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ceesay AbrahamCIK 0001722140 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Common Stock | SSaleDisposed | −39,435 | $26.30 | −$1,037,140.5 | 586,812 | Direct | |
| Sep 17, 2025 | Common Stock | SSaleDisposed | −1,400 | $26.87 | −$37,618 | 585,412 | Direct | |
| Sep 17, 2025 | Common Stock | SSaleDisposed | −34,885 | $26.30 | −$917,475.5 | 46,844 | Indirect | |
| Sep 17, 2025 | Common Stock | SSaleDisposed | −700 | $27.04 | −$18,928 | 46,144 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.